NCT07468708 2026-03-12
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
5 trialsNCT06516510 2025-09-25
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd
Phase EARLY_PHASE1 Terminated
NCT04726033 2024-05-01
CUPID
Telix Pharmaceuticals (Innovations) Pty Limited
Phase EARLY_PHASE1 Completed
NCT01253213 2023-08-01
BR55 in Prostate Cancer: an Exploratory Clinical Trial
Bracco Diagnostics, Inc
Phase EARLY_PHASE1 Completed
NCT02826382 2023-01-12
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Five Eleven Pharma, Inc.
Phase EARLY_PHASE1 Completed